DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atrovent Nasal (Ipratropium Bromide Nasal) - Published Studies


Atrovent Nasal Related Published Studies

Well-designed clinical trials related to Atrovent Nasal (Ipratropium Nasal)

Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. [2008.03]

The effect of ipratropium nasal spray on bronchial methacholine challenge. [2005.09]

Cold-induced rhinitis in skiers--clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. [2001.09]

Ipratropium bromide nasal spray for treatment of rhinorrhea in the laryngectomized patient: a pilot study. [2001.05]

Ipratropium bromide increases the ability of the nose to warm and humidify air. [2000.09]

Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. [1999.08]

Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. [1999.04]

Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial. [1998.11]

Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection. [1998.03]

The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. [1998.01]

Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion. [1997.06]

Ipratropium nasal spray in children with perennial rhinitis. [1997.05]

A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis. [1997.04]

Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea. [1996.12]

Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. [1996.07.15]

A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. [1995.05]

Product characteristics and pharmacokinetics of intranasal ipratropium bromide. [1995.05]

Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. [1994.11]

Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. [1994.03]

A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. [1992.12]

Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. [1992.12]

Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. [1992.08]

The influence of terfenadine and ipratropium bromide alone and in combination on bradykinin-induced nasal symptoms and plasma protein leakage. [1992.07]

Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis. [1992.07]

Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. [1992.06]

Vasomotor rhinitis and the systemic absorption of ipratropium bromide. [1990.06]

Treatment of non-allergic nasal hypersecretion with ipratropium and beclomethasone. [1990.06]

The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study. [1988.11]

Ipratropium bromide treatment of experimental rhinovirus infection. [1988.11]

Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide. [1988.06]

Well-designed clinical trials possibly related to Atrovent Nasal (Ipratropium Nasal)

Elevation of the nasal mucosal surface temperature after warming of the feet occurs via a neural reflex. [2003.06]

A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. [2003.04]

The anticholinergic treatment of allergic perennial rhinitis. [1992.12]

Combined antiviral and antimediator treatment of rhinovirus colds. [1992.10]

The parasympathetic system in exercise-induced rhinorrhoea. [1992.03]

Other research related to Atrovent Nasal (Ipratropium Nasal)

Intranasal ipratropium bromide for the common cold. [2013]

Intranasal ipratropium bromide for the common cold. [2011.07.06]

Intranasal ipratropium bromide for the common cold. [2011]

Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution. [2010.05.01]

Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. [2010.04]

OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold. [2009.12]

Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold. [2009.04]

Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. [2007.01]

Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. [2005.01]

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. [1995.05]

Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis. [1993]

Long-term safety and efficacy study of intranasal ipratropium bromide. [1990.02]

Intranasal ipratropium: literature abstracts and comments. [1989]

Ipratropium bromide in the treatment of the 'rhinorrhoea syndrome'. [1988.09]

Other possibly related research studies

Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance. [2003]

Cholinergic blockade does not alter the nasal congestive response to irritant provocation. [2002.09]

Posttraumatic pseudo-cerebrospinal fluid rhinorrhea. [2001.09]

Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease. [2001.05]

Anticholinergic bronchodilators. [1999.12]

Optimizing treatment options. [1998.12]

Management of rhinitis--the specialist's opinion. [1998.12]

Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways. [1997.11]

Overview of comorbid associations of allergic rhinitis. [1997.02]

Cyclophosphamide-induced facial discomfort. [1994.02]

The use of intranasal anticholinergic agents in the treatment of nonallergic perennial rhinitis. [1992.12]

Intranasal anticholinergic therapy of rhinorrhea. [1992.12]

Brief report: therapeutic manipulations in severe nocturnal asthma. A nonconventional approach in a severe high-risk asthmatic. [1992]

Management of allergic rhinitis: focus on intranasal agents. [1989]

Nasal disorders and anticholinergic therapy. [1987]

Acute bacterial rhinosinusitis in adults: part II. Treatment. [2004.11.01]

Vasomotor rhinitis update. [2004.06]

Treating acute bronchiolitis associated with RSV. [2004.01.15]

Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. [2002]

Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options? [2001]

Nasal hyperreactivity to methacholine measured by acoustic rhinometry in asymptomatic allergic and perennial nonallergic rhinitis. [2000.07]

Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport. [2000.01]

In vivo human models for the study of anticholinergic drugs. [1995.05]

Induction and relief of nasal congestion in ferrets infected with influenza virus. [1995.02]

Topical nasal sprays: treatment of allergic rhinitis. [1994.07]

Effects of antiallergic agents including levocabastine on experimental rhinitis in rats. [1994.03]

Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. [1993.05.05]

Topical pharmacotherapy for allergic rhinitis: new agents. [1992.02]

A gap in surface therapy: topical antihistamines. [1991.05]

The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. [1991.04]

Optimum pharmacological management of chronic rhinitis. [1989.08]

Anti-allergy and anti-asthma drugs. Disposition in infancy and childhood. [1989]

Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. [1988.03]

Treatment of the common cold. [2007.02.15]

Postnasal drip and chronic cough: An open interventional study. [2009.11]

Validation of guinea pig model of allergic rhinitis by oral and topical drugs. [2008.11]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017